Answers are grounded in this paper and cite their sources.
Seasonal influenza is a major cause of acute respiratory infections and imposes a significant burden. The Spanish Ministry of Health recommends influenza vaccination for children aged 6–59 months since the 2022/2023 season, although implementation varies across regions. The objective was to describe influenza incidence, complications, and healthcare resource use among < 18 years old in Spain. Observational study using Telotrón ® database (> 2.2 million individuals across seven Autonomous Communities in Spain). Population < 18 years with clinical diagnosis of influenza across nine seasons (from 2016–2017 to 2024–2025) were included. Influenza-related complications and healthcare resource utilization were assessed for four seasons (from 2021–2022 to 2024–2025). Across the study period, the highest influenza incidence was observed among children aged 24–59 months, 5–11 years, and 12–14 years, and 66.7% occurred in children without pre-existing conditions. Around 23% of children with influenza experienced a complication, with the highest burden in those aged 0–23 months and 24–59 months. Antibiotics were prescribed in 14–18% of influenza cases. Pediatric influenza represents a substantial public health burden in Spain, suggesting that pediatric influenza vaccination among children and adolescents could contribute to reduce the disease burden.
No takes yet. Share an insight, caveat, or question.
Sanz-Muñoz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: